447 related articles for article (PubMed ID: 30134818)
1. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
[TBL] [Abstract][Full Text] [Related]
2. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.
Nguyen T; Johnston S; Clarke L; Smith P; Staines D; Marshall-Gradisnik S
Clin Exp Immunol; 2017 Feb; 187(2):284-293. PubMed ID: 27727448
[TBL] [Abstract][Full Text] [Related]
3. Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target.
Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Jeremijenko A; Griffin P; Marshall-Gradisnik S
Front Immunol; 2024; 15():1264702. PubMed ID: 38765011
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Marshall-Gradisnik S; Johnston S; Chacko A; Nguyen T; Smith P; Staines D
J Int Med Res; 2016 Dec; 44(6):1381-1394. PubMed ID: 27834303
[TBL] [Abstract][Full Text] [Related]
5. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
Eaton N; Cabanas H; Balinas C; Klein A; Staines D; Marshall-Gradisnik S
BMC Pharmacol Toxicol; 2018 Mar; 19(1):12. PubMed ID: 29587879
[TBL] [Abstract][Full Text] [Related]
6. Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review.
Du Preez S; Cabanas H; Staines D; Marshall-Gradisnik S
Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682454
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.
Brenu EW; van Driel ML; Staines DR; Ashton KJ; Hardcastle SL; Keane J; Tajouri L; Peterson D; Ramos SB; Marshall-Gradisnik SM
J Transl Med; 2012 May; 10():88. PubMed ID: 22571715
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome.
Eaton-Fitch N; du Preez S; Cabanas H; Staines D; Marshall-Gradisnik S
Syst Rev; 2019 Nov; 8(1):279. PubMed ID: 31727160
[TBL] [Abstract][Full Text] [Related]
9. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Johnston S; Staines D; Klein A; Marshall-Gradisnik S
BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Brenu EW; Ashton KJ; van Driel M; Staines DR; Peterson D; Atkinson GM; Marshall-Gradisnik SM
J Affect Disord; 2012 Dec; 141(2-3):261-9. PubMed ID: 22572093
[TBL] [Abstract][Full Text] [Related]
11. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Rivas JL; Palencia T; Fernández G; García M
Front Immunol; 2018; 9():1028. PubMed ID: 29867995
[TBL] [Abstract][Full Text] [Related]
12. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels.
Drews A; Mohr F; Rizun O; Wagner TF; Dembla S; Rudolph S; Lambert S; Konrad M; Philipp SE; Behrendt M; Marchais-Oberwinkler S; Covey DF; Oberwinkler J
Br J Pharmacol; 2014 Feb; 171(4):1019-32. PubMed ID: 24251620
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
Chacko A; Staines DR; Johnston SC; Marshall-Gradisnik SM
Gene Regul Syst Bio; 2016; 10():85-93. PubMed ID: 27594784
[TBL] [Abstract][Full Text] [Related]
15. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.
Brenu EW; Huth TK; Hardcastle SL; Fuller K; Kaur M; Johnston S; Ramos SB; Staines DR; Marshall-Gradisnik SM
Int Immunol; 2014 Apr; 26(4):233-42. PubMed ID: 24343819
[TBL] [Abstract][Full Text] [Related]
16. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
de Vega WC; Herrera S; Vernon SD; McGowan PO
BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
[TBL] [Abstract][Full Text] [Related]
18. Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
Huth TK; Brenu EW; Staines DR; Marshall-Gradisnik SM
Gene Regul Syst Bio; 2016; 10():43-9. PubMed ID: 27346947
[TBL] [Abstract][Full Text] [Related]
19. Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo.
Straub I; Krügel U; Mohr F; Teichert J; Rizun O; Konrad M; Oberwinkler J; Schaefer M
Mol Pharmacol; 2013 Nov; 84(5):736-50. PubMed ID: 24006495
[TBL] [Abstract][Full Text] [Related]
20. Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction.
Naylor J; Li J; Milligan CJ; Zeng F; Sukumar P; Hou B; Sedo A; Yuldasheva N; Majeed Y; Beri D; Jiang S; Seymour VA; McKeown L; Kumar B; Harteneck C; O'Regan D; Wheatcroft SB; Kearney MT; Jones C; Porter KE; Beech DJ
Circ Res; 2010 May; 106(9):1507-15. PubMed ID: 20360246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]